Innoviva Board of Directors, Key People and Executives

Health Care & Life Sciences » Pharmaceuticals | Innoviva Inc.

Innoviva Inc. | Key People and Executives

Odysseas Demosthenes Kostas

Chairman

Mark Dipaolo

Director

Jules Haimovitz

Director

Sarah J. Schlesinger

Independent Director

Patrick G. LePore

Vice Chairman

George W. Bickerstaff

Independent Director

Paul Pepe

Independent Director

Catherine J. Friedman

Independent Director

Odysseas Demosthenes Kostas

Chairman

Geoffrey Hulme

Chief Executive Officer

Theodore J. Witek

Chief Scientific Officer & Senior Vice President

George B. Abercrombie

Chief Commercial Officer & Senior Vice President

Mark Dipaolo

Director

Jules Haimovitz

Director

Marianne Zhen

Chief Accounting Officer

Sarah J. Schlesinger

Independent Director

Patrick G. LePore

Vice Chairman

George W. Bickerstaff

Independent Director

Paul Pepe

Independent Director

Catherine J. Friedman

Independent Director

View Profile

Address	2000 Sierra Point Parkway Brisbane California 94005 United States
Employees	-
Website	http://www.inva.com
Updated	07/08/2019
Innoviva, Inc. engages in the development, commercialization, and financial management of bio-pharmaceuticals. Its portfolio includes Relvar Breo Ellipta, which is a once-daily combination medicine consisting of a long-acting beta2 agonist, vilanterol, and an inhaled corticosteroid, fluticasone furoate; and Anoro Ellipta, a once-daily medicine combining a long-acting muscarinic antagonist, umeclidinium bromide, LABA, VI. The company was founded by P.